Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Roivant Sciences (ROIV) Other Operating Expenses (2020 - 2025)

Roivant Sciences' Other Operating Expenses history spans 6 years, with the latest figure at $700000.0 for Q4 2025.

  • For Q4 2025, Other Operating Expenses rose 170.27% year-over-year to $700000.0; the TTM value through Dec 2025 reached $965000.0, up 36.69%, while the annual FY2025 figure was $911000.0, 96.75% down from the prior year.
  • Other Operating Expenses reached $700000.0 in Q4 2025 per ROIV's latest filing, up from $111000.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $16.7 million in Q2 2023 to a low of $111000.0 in Q3 2025.
  • Average Other Operating Expenses over 5 years is $3.2 million, with a median of $259000.0 recorded in 2024.
  • Peak YoY movement for Other Operating Expenses: skyrocketed 868.37% in 2023, then crashed 98.73% in 2024.
  • A 5-year view of Other Operating Expenses shows it stood at $853000.0 in 2021, then surged by 102.34% to $1.7 million in 2022, then crashed by 88.59% to $197000.0 in 2023, then skyrocketed by 31.47% to $259000.0 in 2024, then soared by 170.27% to $700000.0 in 2025.
  • Per Business Quant, the three most recent readings for ROIV's Other Operating Expenses are $700000.0 (Q4 2025), $111000.0 (Q3 2025), and $154000.0 (Q2 2025).